A world first for Bglobal, a Quarto-ly update and Ark increases capacity

Tuesday, May 01 2012 by
A world first for Bglobal a Quartoly update and Ark increases capacity

The FTSE closed last week broadly where it started at around 5,770 points, it had to recover from a significant early week drop (closing last Monday at 5,645 points). The AIM All share had a less troubled week, opening at 780 points and closing at 777. The markets have seen the Spanish economy slip back into recession, having contracted by 0.3 per cent in the first quarter, retail sales sliding in the Eurozone with the PMI for Germany, France and Italy falling from 49.1 to 41.3 and the US economy slowing to an annualised pace of 2.2% in the first quarter of the year, from 3% in the final three months of last year. The week ahead sees manufacturing, construction and services PMI data being announced, BoE mortgage data and a speech by the BoE governor.

Affero Mining (LON:AFF 57.5p/ £60.38m)

Afferro Mining, the exploration and development Company focused on iron ore projects in Cameroon, has reported that following discussions with the Cameroon Government it will be provided the opportunity to access the proposed railway line through the south of Cameroon. In a series of meetings with the Directors of the Company recently, the Cameroon Government has emphasised its commitment that the infrastructure should also serve third party mining projects to develop the nascent Cameroonian iron ore industry. The Company is also in discussions with the Government regarding the possibility of participating in the financing of the special purpose vehicle being set up to develop the railway. Accordingly, the Company is revising its Preliminary Economic Assessment (PEA) to take these developments under consideration and shall be disclosing its findings in May.

Ark Therapeutics (LON:AKT) Group (LON:AKT 3.78p/£7.90m)

Ark Therapeutics Group announced that following inspection of the Company's manufacturing site, the Finnish Medicines Agency has extended Ark's Good Manufacturing Practice (GMP) certification to include the Company's newest and largest production facility, GMP 3. The certification will greatly increase the Company's manufacturing capacity, including an automated "fill and finish" line capable of handling up to 2,000 product units/hour. In response to growing demand for the Company's bio- manufacturing expertise, earlier this month Ark appointed Dr David Venables to the Board as Executive Director - Manufacturing Services. David Venables, Ark's Director of Manufacturing Services commented: "The availability of the GMP 3 suite will allow us…

Unlock this article instantly by logging into your account

Don’t have an account? Register for free and we’ll get out your way

Disclaimer:  

This document should not be relied upon as being an impartial or objective assessment of the subject matter and is not deemed to be "independent research" for the purposes of the Financial Services Authority (FSA) rules. As a consequence the research (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research; and (b) is not subject to any prohibition on dealing ahead of the dissemination of investment research (although Hybridan does impose restrictions on personal account dealing in the run up to publishing research as set out in our Conflicts of Interest Policy).

The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual partners and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document.

This document has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments. The information contained herein is based on materials and sources that we believe to be reliable, however, Hybridan LLP makes no representation or warranty, either express or implied, in relation to the accuracy, completeness or reliability of the information contained herein. Opinions expressed are our current opinions as of the date appearing on this material only. Any opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. None of Hybridan LLP, its affiliates or employees shall have any liability whatsoever for any indirect or consequential loss or damage arising from any use of this document.

In the UK, this report is directed at and is for distribution only to persons who (i) fall within Article 19(1) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties of Hybridan LLP (all such persons together being referred to as "relevant persons"). This report must not be acted on or relied up on by persons in the UK who are not relevant persons.

Neither this report nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this report comes should inform themselves about, and observe any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Investments in general involve some degree of risk, including the risk of capital loss. The services, securities and investments discussed in this document may not be available to or suitable for all investors. Investors should make their own investment decisions based upon their own financial objectives and financial resources and, if in any doubt, should seek advice from an investment advisor. Past performance is not necessarily a guide to future performance and an investor may not get back the amount originally invested. Where investment is made in currencies other than the investor?s base currency, movements in exchange rates will have an effect on the value, either favourable or unfavourable. Levels and bases for taxation may change. When Hybridan LLP comments on AIM or PLUS Markets shares investors should be aware that because the rules for those markets are less demanding than the Official List of the London Stock Exchange the risks are higher. Furthermore, the marketability of these shares is often restricted.

Hybridan LLP and/or its associated companies may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the partners, directors and employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests. Neither the whole nor any part of this material may be duplicated in any form or by any means. Neither should any of this material be redistributed or disclosed to anyone without the prior consent of Hybridan LLP. Hybridan LLP is Authorised and Regulated by the Financial Services Authority and is a member of the London Stock Exchange.


Hybridan LLP
29 Throgmorton Street, London EC2N 2AT

If you would like to receive other research reports from Hybridan, or would like to unsubscribe, please e- mail research@hybridan.com, title e-mail "research reports" or "unsubscribe me" Hybridan LLP is authorised and regulated by the Financial Services Authority Member of the London Stock Exchange


Do you like this Post?
Yes
No
0 thumbs up
0 thumbs down
Share this post with friends




Flowgroup plc and its subsidiaries are focused on the creation of shareholder value through the provision of a range of energy technologies, energy supply and energy services. The Company's segments include Flow Products and Flow Battery. Its Flow Products segment provides products for distributed generation and load shifting. Its Flow Battery segment provides compressed air battery products. Flow Products offers heating and microgeneration products and delivers them into the market through a national network of installers-Flow Brand Ambassadors. The Company's product range include Flow boiler, which is the domestic microCHP boiler that generates low carbon electricity while it uses gas to heat a home and Hybrid system that combines heat pump technology with a system boiler. Its subsidiaries include Flow Products Limited, Flow Battery Limited and Energetix Europe Limited. more »

LSE Price
0.015p
Change
 
Mkt Cap (£m)
n/a
P/E (fwd)
n/a
Yield (fwd)
n/a




  Is LON:CSLT fundamentally strong or weak? Find out More »


Please subscribe to submit a comment




About Hybridan

Hybridan

Hybridan is a corporate broker and PLUS markets corporate advisor specialising in fundraising, research and after-market support for small and micro cap companies. We utilise our market knowledge to provide creative financing solutions and strong after-market support. We build long term durable relationships with companies and investors, for the benefit of both. This long term approach, coupled with a high degree of selectivity, yields investments that outperform the market. more »



Stock Picking Tutorial Centre



Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis